CPhI Global Portfolio Expands into South East Asia

AMSTERDAM, October 25, 2011 -

Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced the introduction of a new event, CPhI South East Asia to cater to the pharmaceutical ingredients market, that will debut in 2012 from 10 to 12 May at the Jakarta International Expo in Indonesia. The latest member of the CPhI global portfolio of pharmaceutical events is being introduced to offer a meeting place for pharmaceutical professionals in this quickly growing region. The show will offer exhibitors and visitors the opportunity to establish new business opportunities and network with key decision makers in the pharmaceutical industry within the ASEAN region.

In 2010, Indonesia’s pharmaceutical market had an estimated value of US$3.9 billion, which represented an increase of more than 10% from the previous year. This growth is expected to continue and is coupled with new legislative reforms that are allowing the ASEAN market to drastically change its relationship with the global market. At present, Indonesia currently has around 200 pharmaceutical manufacturers with around one fifth having foreign investment. There is also a big generics sector, which accounts for three-quarters of total pharma sales, that is controlled by four state-owned companies who have about 70% of the market. Planned reforms include expanding the allowance for foreign investors to own drug companies from the current 75% to a full 100%. The aim is to persuade the big pharma companies to build Indonesian production facilities and create manufacturing and supply hubs for the rest of the region.

“Indonesia is the ideal location for the introduction of a new CPhI event. The South East Asia region is an exceptional example of a “pharmerging” market and we feel that it is key to establish presence here at this time. The new event offers visitors with a unique opportunity to access an area that is aligning itself for explosive growth,” noted Greg Kerwin, UBM Pharma Portfolio Director. “The pharmaceutical market is growing across the region, and the increased demand for pharma raw materials offers great potential for international suppliers to expand their footprint in the ASEAN companies. CPhI effectively provides a one-stop-shop for meeting new potential customers and partners in these growth territories.”

To learn more about CPhI South East Asia and to register for attendance for free, please visit: www.cphi-sea.com/

UBM Lives’ market leading schedule of co-located annual events include CPhI India (30 November - 2 December, 2011, Bombay Exhibition Centre, Mumbai), Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Center, Japan), China (26-28 June, 2012, SNIEC, Shanghai, China), South America (21-23 August, 2012, Transamerica Expo Centre, Brazil) and Worldwide (9-11 October, 2012 at the Feria de Madrid, Spain).

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.

Media Enquiries: Impress Labs, Global (excl. North America): Richard Kerns, richard at impresslabs.com, +44-161-728-5880, or North America: Beth Willers, beth at impresslabs.com, +1-503-928-7828; or Company Enquiries: UBM Live, Ian O’Malley, +31-20-40-99-5526